https://www.selleckchem.com/pr....oducts/oligomycin-a.
003), as well as a significantly shorter hospital stay (p 0.001). SMOF Lipid infusion seemed to have improved GCS, the prolonged QTc interval, and shortened the length of hospital stay. Furthermore, there were no adverse effects related to its administration. SMOF Lipid infusion seemed to have improved GCS, the prolonged QTc interval, and shortened the length of hospital stay. Furthermore, there were no adverse effects related to its administration.Aim We performed an updated meta-analysis to evaluate the efficacy and safety o